Icon

SINEMET CR (nda019856)- (25MG;100MG,50MG;200MG)

CARBIDOPA; LEVODOPA ORGANON LLC
25MG;100MG,50MG;200MG
Yes No
2006-Jun-16 Expired
None None
None No
SINEMET CR is indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
8 0 7
Total Other Developers 5
Drugs with Suitability No
25MG;100MG ** ** - - 5
50MG;200MG ** ** - - 5
NDA Sales Available Total Generic Sales Available
No 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ********** *** *** *********** ** ****** **, ****** ****, *** ****, ********* (***) ***
****** ***** ***** *************** ***. *********** **** ******* ***** ****, **********, **** ******** (**) *****, ****** ****** (***) ***
****** ***** **** ****** *************** ******* ******* *********** ****** **.***, *** ** ***, **** ***** ********* *******-***** *******, ******* ******, *** *****, *********, ******* ******, ***** (***) ***
****** *** ***** **** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********** ********, ******* *******, *.*. *******, **** *****, ****** *****,, **********, ******* ******, ***** (***) ***
****** ******* ****** *** ******* ***************, ***. *********** ** ***** *****, *********, *** **** (**) *****-****, ****** ****** (***) ***
****** ******* ****** *** ******* ***************, ***. *********** *** **** ******, *********, *** **** (**) *****-****, ****** ****** (***) ***
****** ******* ******* ******** ******* *********** **** ** *-**/* & ***/*, ****, ********** ********* ****,, *****, *********** *** ***, ***** (***) ***

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.